• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

JSH-23

CAS No. 749886-87-1

JSH-23 ( NF-κB Activation Inhibitor II )

产品货号. M15858 CAS No. 749886-87-1

JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥515 有现货
5MG ¥853 有现货
10MG ¥1159 有现货
25MG ¥1841 有现货
50MG ¥2762 有现货
100MG ¥3978 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥917 有现货

生物学信息

  • 产品名称
    JSH-23
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    JSH-23 是 NF-κB 转录活性的抑制剂,IC50 为 7.1 μM。
  • 产品描述
    JSH-23 is an inhibitor of NF-κB transcriptional activity with IC50 of 7.1 μM.(In Vitro):JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.(In Vivo):JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats.
  • 体外实验
    JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells.Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner.Cell Cytotoxicity Assay Cell Line:Macrophages RAW 264.7 Concentration:1, 3, 10, 30, 100, 300 μM Incubation Time:24 hours Result:Did not show significant cytotoxic effects at <100 μM.Western Blot Analysis Cell Line:Macrophages RAW 264.7 with LPS-stimulated Concentration:30 μM Incubation Time:1 hour Result:Decreased nuclear content of NF-κB p65 in a dose-dependent manner, corresponding to 49±4% inhibition at 3 μM, 75±7% at 10 μM and 95±8% at 30 μM.
  • 体内实验
    JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats. Animal Model:Male Sprague Dawley diabetic rats (250-270 g)Dosage:1 mg/kg, 3 mg/kg Administration:Orally administered; daily; for 2 weeks Result:Produced significant improvement in motor nerve conduction velocity (MNCV).
  • 同义词
    NF-κB Activation Inhibitor II
  • 通路
    Apoptosis
  • 靶点
    NF-κB
  • 受体
    NF-κB
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    749886-87-1
  • 分子量
    240.34
  • 分子式
    C16H20N2
  • 纯度
    >98% (HPLC)
  • 溶解度
    Ethanol: 20 mg/mL (83.21 mM); DMSO: 48 mg/mL (199.71 mM)
  • SMILES
    NC1=CC(C)=CC=C1NCCCC2=CC=CC=C2
  • 化学全称
    4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Kasparkova J, et al. FEBS J. 2014, doi: 10.1111/febs.1271
产品手册
关联产品
  • Iguratimod

    一种新型缓解疾病抗风湿化合物,可抑制 NF-κB (NF-κB) p65 亚基 (RelA) 磷酸化和核转位,而不影响 IKBα 降解。

  • AP-1/NF-κB activatio...

    AP-1/NF-κB activation inhibitor 1 是一种有效的 AP-1 和NF-κB 介导的转录激活抑制剂(IC50=1 μM),不阻断 β-actin 启动子驱动的基础转录。AP-1/NF-κB activation inhibitor 1 对受刺激细胞产生IL-2和IL-8水平有相似的抑制作用。

  • Amgen16

    Amgen 16 (Amgen16) 是一种高效的 NF-κB 诱导激酶 (NIK) 抑制剂,Ki 为 2 nM。